$18 Million Expansion of Tempur-Pedic's Global Headquarters in Lexington to Create 65 Jobs
10/03/2011
Tempur-Pedic is a billion-dollar company that started in Lexington, Kentucky, in 1993. It develops, manufactures, and markets advanced sleep products sold in over 80 countries. Tempur-Pedic CEO Mark Sarvary said his firm "couldn't be more pleased that our success is driving expansion into a new facility, creating new job opportunities right here in the heart of the Bluegrass."
The Kentucky Economic Development Finance Authority preliminarily approved Tempur-Pedic for performance-based tax incentives up to $8 million through the Kentucky Business Investment program. The incentive allows the company to keep a portion of its investment over a five-year period through corporate income tax credits and wage assessments by meeting job/investment targets.
A state-funded impact study shows the number of direct, indirect, and induced jobs that will result from Tempur-Pedic's existing and new employment is 772, and that these jobs provide an annual $72.8 million boost to Kentucky's GDP.
Project Announcements
Electric Research and Manufacturing Cooperative Plans Waddell, Arizona, Transformer Production Operations
01/23/2026
Viking Attachments Expands Morgan City, Louisiana, Manufacturing Operations
01/23/2026
France-Based Reju Plans Rochester, New York, Textile Regeneration Operations
01/23/2026
Heil Trailer International Expands Athens, Tennessee, Manufacturing Operations
01/23/2026
Ampirical Expands Covington, Louisiana, Operations
01/23/2026
Laser Isotope Separation Technologies Plans Oak Ridge, Tennessee, Uranium Enrichment Operations
01/22/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025